Literature DB >> 3577475

Borrelia burgdorferi lipopolysaccharide and its role in the pathogenesis of Lyme disease.

G S Habicht, G Beck, J L Benach, J L Coleman.   

Abstract

Lipopolysaccharides (LPS) are a constitutive part of the outer wall of gram negative bacteria. Because many of the symptoms of Lyme disease could be explained by a spirochetal LPS we have subjected Borrelia burgdorferi to standard LPS extraction techniques which yielded a LPS which accounted for 1.5-4% of the dry weight. The LPS was very similar to classical gram negative bacterial LPS both chemically and in its biological activities which included pyrogenicity, mitogenicity for lymphocytes and the induction of Interleukin 1 production by macrophages. In addition, the LPS produced an acute inflammatory reaction when injected intradermally into rabbit skin. It could also prepare a skin site for the production of the local Shwartzman reaction. These results show that the Lyme disease spirochete contains a hitherto unknown LPS that is biologically active in vitro and in vivo. It is likely that this molecule plays an important role in the pathogenesis of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3577475     DOI: 10.1016/s0176-6724(86)80115-8

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  4 in total

1.  Identification of an immunoreactive non-proteinaleous component in Borrelia burgdorferi.

Authors:  H Eiffert; H Lotter; K Jarecki-Khan; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Thermoregulation of protein synthesis in Borrelia burgdorferi.

Authors:  R G Cluss; J T Boothby
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Purification and immunological characterization of a major low-molecular-weight lipoprotein from Borrelia burgdorferi.

Authors:  L I Katona; G Beck; G S Habicht
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

4.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.